BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Celhar T, Fairhurst AM. Modelling clinical systemic lupus erythematosus: similarities, differences and success stories. Rheumatology (Oxford) 2017;56:i88-99. [PMID: 28013204 DOI: 10.1093/rheumatology/kew400] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zazara DE, Arck PC. Developmental origin and sex-specific risk for infections and immune diseases later in life. Semin Immunopathol 2019;41:137-51. [DOI: 10.1007/s00281-018-0713-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
2 González-correa C, Moleón J, Miñano S, Visitación NDL, Robles-vera I, Gómez-guzmán M, Jiménez R, Romero M, Duarte J. Trimethylamine N-Oxide Promotes Autoimmunity and a Loss of Vascular Function in Toll-like Receptor 7-Driven Lupus Mice. Antioxidants 2022;11:84. [DOI: 10.3390/antiox11010084] [Reference Citation Analysis]
3 Gubbels Bupp MR, Jorgensen TN. Androgen-Induced Immunosuppression. Front Immunol 2018;9:794. [PMID: 29755457 DOI: 10.3389/fimmu.2018.00794] [Cited by in Crossref: 102] [Cited by in F6Publishing: 95] [Article Influence: 25.5] [Reference Citation Analysis]
4 Liu L, Takeda K, Akkoyunlu M. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus. Front Immunol 2020;11:1569. [PMID: 32849532 DOI: 10.3389/fimmu.2020.01569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Huang MW, Stock AD, Mike EV, Herlitz L, Kolbeck R, Putterman C. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/lpr lupus mice. Lupus 2019;28:1510-23. [PMID: 31474191 DOI: 10.1177/0961203319872265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Sanghera C, Wong LM, Panahi M, Sintou A, Hasham M, Sattler S. Cardiac phenotype in mouse models of systemic autoimmunity. Dis Model Mech 2019;12:dmm036947. [PMID: 30858306 DOI: 10.1242/dmm.036947] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
7 Martín-Márquez BT, Satoh M, Hernández-Pando R, Martínez-García EA, Petri MH, Sandoval-García F, Pizano-Martinez O, García-Iglesias T, Corona-Meraz FI, Vázquez-Del Mercado M. The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane. PLoS One 2021;16:e0259114. [PMID: 34705865 DOI: 10.1371/journal.pone.0259114] [Reference Citation Analysis]
8 Pollard KM, Cauvi DM, Mayeux JM, Toomey CB, Peiss AK, Hultman P, Kono DH. Mechanisms of Environment-Induced Autoimmunity. Annu Rev Pharmacol Toxicol 2021;61:135-57. [PMID: 32857688 DOI: 10.1146/annurev-pharmtox-031320-111453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Han X, Vesely MD, Yang W, Sanmamed MF, Badri T, Alawa J, López-Giráldez F, Gaule P, Lee SW, Zhang JP, Nie X, Nassar A, Boto A, Flies DB, Zheng L, Kim TK, Moeckel GW, McNiff JM, Chen L. PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus. Sci Transl Med 2019;11:eaax1159. [PMID: 31826980 DOI: 10.1126/scitranslmed.aax1159] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
10 Xiang L, Liu A, Xu G. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice. Am J Physiol Renal Physiol 2020;318:F1258-70. [PMID: 32249615 DOI: 10.1152/ajprenal.00472.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Al Khalili A, Dutz JP. Janus Kinase Inhibition and SLE: Is this a Plausible Treatment Option for SLE? Curr Treat Options in Rheum 2020;6:406-17. [DOI: 10.1007/s40674-020-00155-w] [Reference Citation Analysis]
12 Treger RS, Pope SD, Kong Y, Tokuyama M, Taura M, Iwasaki A. The Lupus Susceptibility Locus Sgp3 Encodes the Suppressor of Endogenous Retrovirus Expression SNERV. Immunity 2019;50:334-347.e9. [PMID: 30709743 DOI: 10.1016/j.immuni.2018.12.022] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 13.7] [Reference Citation Analysis]
13 Xu WD, Huang AF. Role of Interleukin-38 in Chronic Inflammatory Diseases: A Comprehensive Review. Front Immunol 2018;9:1462. [PMID: 29988385 DOI: 10.3389/fimmu.2018.01462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
14 Moore E, Putterman C. Are lupus animal models useful for understanding and developing new therapies for human SLE? J Autoimmun 2020;112:102490. [PMID: 32535128 DOI: 10.1016/j.jaut.2020.102490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li W, Chen W, Huang S, Tang X, Yao G, Sun L. Infection with Opportunistic Bacteria Triggers Severe Pulmonary Inflammation in Lupus-Prone Mice. Mediators Inflamm 2019;2019:1701367. [PMID: 31565032 DOI: 10.1155/2019/1701367] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 de la Visitación N, Robles-Vera I, Moleón J, González-Correa C, Aguilera-Sánchez N, Toral M, Gómez-Guzmán M, Sánchez M, Jiménez R, Martin-Morales N, O'Valle F, Romero M, Duarte J. Gut Microbiota Has a Crucial Role in the Development of Hypertension and Vascular Dysfunction in Toll-like Receptor 7-Driven Lupus Autoimmunity. Antioxidants (Basel) 2021;10:1426. [PMID: 34573058 DOI: 10.3390/antiox10091426] [Reference Citation Analysis]
17 Strasser DS, Froidevaux S, Sippel V, Gerossier E, Grieder U, Pierlot GM, Kieninger-Graefitsch A, Vezzali E, Stalder AK, Renault B, Ryge J, Hart A, Mentzel U, Groenen PMA, Keller MP, Trendelenburg M, Martinic MM, Murphy MJ. Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus. RMD Open 2020;6:e001261. [PMID: 32917831 DOI: 10.1136/rmdopen-2020-001261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kaneko Y, Fukahori H, Yamagami K, Kawashima T, Ito M, Akamatsu M, Marui T, Kato K, Takahashi F, Morokata T. Effects of AS2819899, a novel selective PI3Kδ inhibitor, in a NZB/W F1 mouse lupus-like nephritis model. Int Immunopharmacol 2020;87:106764. [PMID: 32736191 DOI: 10.1016/j.intimp.2020.106764] [Reference Citation Analysis]
19 Sakunrangsit N, Pholtaisong J, Sucharitakul J, Wanna-Udom S, Prombutara P, Pisitkun P, Leelahavanichkul A, Aporntewan C, Greenblatt MB, Lotinun S. Identification of candidate regulators of mandibular bone loss in FcγRIIB-/- Mice. Sci Rep 2021;11:18726. [PMID: 34548536 DOI: 10.1038/s41598-021-98108-3] [Reference Citation Analysis]